OGI - OrganiGram Holdings Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.6000
-0.1300 (-3.49%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close3.7300
Open3.7400
Bid3.5600 x 1300
Ask3.5900 x 900
Day's Range3.4700 - 3.8000
52 Week Range2.7100 - 8.4400
Volume2,107,864
Avg. Volume1,293,917
Market Cap558.162M
Beta (3Y Monthly)2.37
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • Business Wire

    Organigram Awarded Excellence in Manufacturing Consortium Award

    Organigram Holdings Inc. (OGI) (OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company was recognized at the Excellence in Manufacturing Consortium (“EMC”) Awards of Excellence ceremony in Toronto on October 9.

  • Business Wire

    Organigram Assumes Board Positions on International Cannabis Industry Advocacy Organizations

    Organigram Holdings Inc. (OGI) (OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that a representative of the Company has assumed board positions with three international organizations committed to promote and foster global cannabis industry growth: The American Trade Association for Cannabis and Hemp, The Policy Center for Public Health & Safety (both U.S.-based) and the European Alliance for Medical Cannabis.

  • GlobeNewswire

    Organigram Holdings Inc. CEO Discusses Rampant Growth in Exclusive NetworkNewsWire Broadcast

    NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI), parent company of Organigram Inc., today announces the broadcast of its audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community. Organigram CEO Greg Engel, a 30-year veteran of the pharmaceuticals, biotech, consumer packed goods and cannabis sectors, joins NNW’s Stuart Smith in an interview that discusses the company’s dramatic growth within Canada and its strategic expansion on a global scale. As one of the original 15 Canadian cannabis companies focused on the medical cannabis space, Organigram has evolved to serve Canada’s adult recreational market and sees significant opportunity in the country’s upcoming legalization of edible and derivative products.

  • Newsfile

    BTV Uncovers Companies in the Growing Cannabis Sector

    Vancouver, British Columbia--(Newsfile Corp. - September 26, 2019) - On national TV Sat. Sept. 28 & Sun. Sept. 29, 2019 - As the Canadian cannabis sector remains strong, BTV- Business Television visits thriving opportunities ripe for investment.Click company name to watch their feature:Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) - With insight from David Kideckel, Managing Director and Senior Equity Research Analyst, Healthcare & Life Sciences at AltaCorp. BTV drops in on one ...

  • Business Wire

    Organigram Receives Health Canada Approval to Bring Total Licensed Production Capacity to Target of 76,000 kg/yr1

    Organigram Holdings Inc. (OGI) (OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that effective September 6, 2019 it has received Health Canada’s approval for the licensing of 17 additional cultivation rooms under the Cannabis Regulations. The new cultivation rooms represent approximately 15,000 kg/yr1 of increased target production capacity.

  • ACCESSWIRE

    OrganiGram Holdings, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / July 15, 2019 / OrganiGram Holdings, Inc. (NASDAQ: OGI ) will be discussing their earnings results in their 2019 Third Quarter Earnings to be held on July 15, 2019, 2018 at ...

  • CNW Group

    Organigram Holdings Inc. to Report Third Quarter Fiscal 2019 Results on July 15, 2019

    Organigram Holdings Inc. to Report Third Quarter Fiscal 2019 Results on July 15, 2019

  • CNW Group

    Organigram Receives Health Canada Approval for an Additional 17 Cultivation Rooms in Phase 4A

    MONCTON, NB , June 24, 2019 /CNW/ - Organigram Holdings Inc. (OGI) (OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that it has received approval from Health Canada for the licensing of 17 additional cultivation rooms within the Phase 4A/ 4B perimeter of the building. Thirteen of 31 Phase 4A cultivation rooms originally contemplated have previously been licensed. The 31st room initially contemplated for Phase 4A is being moved from the Company's 4A plans to its 4B licensing plans thereby adjusting Phase 4A from 31 to 30 rooms and Phase 4B from 32 rooms to 33 rooms.

  • CNW Group

    Organigram sends first shipment to Quebec; Organigram products now available in all ten provinces

    MONCTON, NB , June 20, 2019 /CNW/ - Organigram Holdings Inc. (OGI) (OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that it has now shipped its first cannabis products to the province of Quebec , following purchase orders placed with the Société québécoise du cannabis (SQDC) and following registration with the Autorité des Marchés Publics. A true national player in Canada's legal adult use recreational cannabis marketplace, the Company has now distributed products for sale to all ten Canadian provinces.

  • Organigram becomes exclusive Canadian supplier of Feather Company's design-patented vaporizer hardware and technology
    CNW Group

    Organigram becomes exclusive Canadian supplier of Feather Company's design-patented vaporizer hardware and technology

    Organigram becomes exclusive Canadian supplier of Feather Company's design-patented vaporizer hardware and technology

  • PR Newswire

    Organigram Secures Partnership with PAX as Brand Partner

    MONCTON, NB, June 7, 2019 /PRNewswire/ – Organigram Holdings Inc. (OGI) (OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis and extract-based products, is pleased to announce it has been selected as one of the four Canadian launch partners of PAX Era, the premium oil vaporizer created by PAX Labs, Inc., a leading consumer technology brand in the design and development of premium vaporizers for dry flower and concentrates, when concentrates become legal in Canada later this year.

  • PAX Labs Partners With Canadian Licensed Producers Aphria, Aurora, Organigram and Supreme Cannabis
    CNW Group

    PAX Labs Partners With Canadian Licensed Producers Aphria, Aurora, Organigram and Supreme Cannabis

    TORONTO , June 7, 2019 /CNW/ - PAX Labs, Inc., a leading consumer technology brand in cannabis, is pleased to announce that Aphria Inc. ("Aphria") (APHA.TO)(APHA), Aurora Cannabis Inc. ("Aurora") (ACB.TO)(ACB), Organigram Holdings Inc. ("Organigram") (OGI.V)(OGI), and The Supreme Cannabis Company, Inc. ("Supreme Cannabis") (FIRE.TO) have signed on as PAX Era brand partners. PAX designs and develops premium vaporizers for cannabis flower and concentrates. As brand partners, the licensed producers (LPs) will offer high quality products from their various brands in pods compatible with the design-forward PAX Era device.

  • CNW Group

    Supreme Cannabis Announces Exclusive Partnership with PAX Labs

    Supreme Cannabis Announces Exclusive Partnership with PAX Labs